Insulin signaling and action in fat cells: Associations with insulin resistance and Type 2 diabetes

Annals of the New York Academy of Sciences

Volumn 892, Issue , 1999, Pages 119-126

  Smith, Ulf ^a   Axelsen, Mette ^a   Carvalho, Eugenia ^a   Eliasson, Björn ^a   Jansson, Per Anders ^a   Wesslau, Christian ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOCKING PROTEIN; FATTY ACID; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; LIPID; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE B; SERINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; DNA FLANKING REGION; DOSE RESPONSE; ENZYME ACTIVITY; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; HYDROLYSIS; INSULIN RESISTANCE; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHORYLATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYNDROME X;

EID: 0032762661     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07790.x     Document Type: Conference Paper

References (27)

1. 1. Alberti, K. G. & P. Z. Zimmet. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet. Med. 15: 539-553.
2. 2. Reaven, G. M. 1988. The role of insulin resistance in human disease. Diabetes 37: 1595-1607.
3. 3. Reaven, G. M. 1995. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75: 473-486.
4. 4. Laakso, M. & E. Barrett-Connor. 1989. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favouring atherosclerosis. Arteriosclerosis 9: 665-672.
5. 5. Axelsen, M., U. Smith, J. Eriksson, M-R. Taskinen & P-A. Jansson. 1999. Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Ann. Intern. Med. 131: 27-31.
6. 6. Beck-Nielsen, H. & L. Groop. 1994. Metabolic and genetic characterization of prediabetic states. J. Clin. Invest. 94: 1714-1721.
7. 7. Rimm, E. B., J. E. Manson, M. J. Stampfer, G. A. Colditz, W. C. Willett, et al. 1993. Cigarette smoking and the risk of diabetes in women. Am. J. Public Health 83: 211-214.
8. 8. Lapidus, L., C. Bengtsson, L. Lissner & U. Smith. 1992. Family history of diabetes in relation to different types of obesity and change of obesity during 12-yr. period. Diabetes Care 15: 1455-1458.
9. 9. Shaw, J. T. E., D. M. Purdie, H. A. W. Neil, J. C. Levy & R. C. Turner. 1999. The relative risks of hyperglycemia, obesity and dyslipidemia in the relatives of patients with type 2 diabetes mellitus. Diabetologia 42: 24-27.
10. 10. Dresner, A., D. Laurent, M. Marcucci, M. Griffin, S. Dufour, et al. 1999. Effects of free fatty acids on glucose transport and IRS 1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103: 253-259.
11. 11. Bulangu, L., B. L. Nyomba, V. M. Ossowski, C. Bogardus & D. M. Mott. 1990. Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. Am. J. Physiol. 258: 964-974.
12. 12. Rondinone, C. M., L-M. Wang, P. Lonnroth, C. Wesslau, J. H. Pierce & U. Smith. 1997. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 94: 4171-4175.
13. 13. Araki, E., M. A. Lipes, M. E. Patti, J. C. Bruning, B. Haag, R. S. Johnson & C. R. Kahn. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190.
14. 14. Patti, M. E., X. J. Sun, J. C. Bruening, E. Arkai, M. A. Lipes, M. F. White & C. R. Kahn. 1995. IRS-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J. Biol. Chem. 270: 24670-24673.
15. 15. Bjornholm, M., Y. Kawano, M. Lehtihet & J. R. Zierath. 1997. Insulin receptor substrate phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: 524-527.
16. 16. Goodyear, L. J., F. Giorgino, L. A. Sherman, J. Carey, R. J. Smith & G. L. Dohm. 1995. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95: 2195-2204.
17. 17. De Fea, K. & R. Roth. 1997. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J. Biol. Chem. 272: 31400-31406.
18. 18. Calera, M. R., C. Martinez, H. Liu, A. K. Jack, M. J. Birnbaum & P. F. Pilch. 1998. Insulin increases the association of Akt-2 with Glut 4-containing vesicles. J. Biol. Chem. 273: 7201-7204.
19. 19. Kohn, A. D., S. A. Summers, M. J. Birnbaum & R. Roth. 1996. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271: 31372-31378.
20. 20. Downward, J. 1998. Mechanisms and consequences of activation of proteins kinase B/Akt. Curr. Opin. Cell Biol. 10: 262-267.
21. 21. Rondinone, C. M., E. Carvalho, C. Wesslau & U. Smith. 1999. Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid, in adipocytes from NIDDM subjects. Diabetologia 42: 819-825.
22. 22. Zierath, J. R., J. N. Livingston, A. Thorne, J. Bolinder, S. Reynisdottir, F. Lonnqvist & P. Arner. 1998. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41: 1343-1354.
23. 23. Stephens, J. M., J. Lee & P. F. Pilch. 1997. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor - mediated signal transduction. J. Biol. Chem. 272: 971-976.
24. 24. Zilversmit, D. 1979. Atherogenesis: a postprandial phenomenon. Circulation 60: 473-485.
25. 25. Syvanne, M. & M-R. Taskinen. 1997. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 350 (Suppl. 1): 20-23.
26. 26. Eliasson, B., N. Mero, M-R. Taskinen & U. Smith. 1997. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 129: 79-88.
27. 27. Phung, T., A. Roncone, K. L. Jensen, C. E. Sparks & J. D. Sparks. 1997. Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J. Biol. Chem. 272: 30693-30702.